W Harb

Publications (1)

An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study.

The Lancet. Haematology

Avec: Michael R Savona , Olatoyosi Odenike , Philip C Amrein , David P Steensma , Amy E DeZern , Laura C Michaelis , Stefan Faderl , Wael Harb , Hagop Kantarjian , James Lowder , Aram Oganesian , Mohammad Azab , Guillermo Garcia-Manero

Réseau de co-auteurs

Michael R Savona 1 collaboration

Olatoyosi Odenike 1 collaboration

Philip C Amrein 1 collaboration

David P Steensma 1 collaboration

Amy E DeZern 1 collaboration

Laura C Michaelis 1 collaboration

Stefan Faderl 1 collaboration

Wael Harb 1 collaboration

Hagop Kantarjian 1 collaboration

James Lowder 1 collaboration

Aram Oganesian 1 collaboration

Mohammad Azab 1 collaboration

Guillermo Garcia-Manero 1 collaboration